Your session is about to expire
← Back to Search
Behavioral Weight Loss + Cardiac Rehab for Atrial Fibrillation and Obesity (BE-WEL in CR Trial)
BE-WEL in CR Trial Summary
This trial will test whether adding behavioral weight-loss treatment to traditional cardiac rehabilitation helps people with atrial fibrillation and obesity experience relief from their symptoms.
BE-WEL in CR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBE-WEL in CR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BE-WEL in CR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I have had at least 2 episodes of AF in the last 6 months or an AF episode that lasted 7 days or more.You are currently taking part in a program to lose weight at the same time.I am scheduled for a procedure to treat my irregular heartbeat.My BMI is 30 or higher.My heart disease is not under control.I have had atrial fibrillation continuously for 3 years or more.
- Group 1: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For what size of participant pool is this trial recruiting?
"Affirmative, clinicaltrials.gov reports that this trial is currently accepting recruits. This research project was first posted on January 24th 2022 and underwent its last update in October 2021. A total of 40 volunteers will be taken from a single medical site for the study's duration."
Is the medical research currently seeking participants?
"Affirmative, the information provided on clinicaltrials.gov states that this research trial is actively recruiting participants. The project commenced on January 24th 2022 and was most recently amended in October 31st 2022. 40 people are needed to enroll from one centre."
What are the research goals of this investigation?
"This medical trial is expected to last 12 weeks, its primary objective being the evaluation of Intervention Feasibility. Secondary goals include evaluating Atrial fibrillation Effect on Quality-of-Life Questionnaire (AFEQT), Beck Depression Inventory - II (BDI - II) and Beck Anxiety Inventory (BAI) scores for symptoms of Psychological Distress along with University Of Toronto AF Symptom Severity Scale (AFSS). The assessments will measure changes in patient's quality of life over time as well as global wellbeing."
Share this study with friends
Copy Link
Messenger